

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 8.97702348 |
| 2 | drug transport (GO:0015893) | 8.71517626 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 8.17190572 |
| 4 | organic cation transport (GO:0015695) | 8.12039479 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 8.03049481 |
| 6 | phosphate ion transport (GO:0006817) | 7.94185520 |
| 7 | lysine metabolic process (GO:0006553) | 7.87922970 |
| 8 | lysine catabolic process (GO:0006554) | 7.87922970 |
| 9 | lipoprotein transport (GO:0042953) | 7.62233168 |
| 10 | drug catabolic process (GO:0042737) | 7.48837967 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 7.28510584 |
| 12 | regulation of bile acid biosynthetic process (GO:0070857) | 6.67750112 |
| 13 | quaternary ammonium group transport (GO:0015697) | 6.52323890 |
| 14 | exogenous drug catabolic process (GO:0042738) | 6.50392378 |
| 15 | positive regulation of guanylate cyclase activity (GO:0031284) | 6.45381359 |
| 16 | phosphate ion transmembrane transport (GO:0035435) | 6.41068382 |
| 17 | vitamin D metabolic process (GO:0042359) | 6.09861687 |
| 18 | excretion (GO:0007588) | 6.01076477 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.99391234 |
| 20 | response to mercury ion (GO:0046689) | 5.91828682 |
| 21 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 5.82625292 |
| 22 | endocrine process (GO:0050886) | 5.82625292 |
| 23 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 5.82625292 |
| 24 | hormone catabolic process (GO:0042447) | 5.78740891 |
| 25 | phosphate ion homeostasis (GO:0055062) | 5.67500628 |
| 26 | trivalent inorganic anion homeostasis (GO:0072506) | 5.67500628 |
| 27 | modified amino acid transport (GO:0072337) | 5.67434966 |
| 28 | renal absorption (GO:0070293) | 5.66855946 |
| 29 | tricarboxylic acid metabolic process (GO:0072350) | 5.57097257 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 5.54403708 |
| 31 | cysteine metabolic process (GO:0006534) | 5.51024479 |
| 32 | toxin transport (GO:1901998) | 5.44735923 |
| 33 | homocysteine metabolic process (GO:0050667) | 5.28368740 |
| 34 | regulation of systemic arterial blood pressure (GO:0003073) | 5.25759517 |
| 35 | cellular glucuronidation (GO:0052695) | 5.19598790 |
| 36 | metanephric tubule development (GO:0072170) | 5.19403974 |
| 37 | metanephric nephron tubule development (GO:0072234) | 5.19403974 |
| 38 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.10344692 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 5.10005270 |
| 40 | regulation of cGMP biosynthetic process (GO:0030826) | 5.06978496 |
| 41 | amino-acid betaine transport (GO:0015838) | 4.90267878 |
| 42 | carnitine transport (GO:0015879) | 4.90267878 |
| 43 | short-chain fatty acid metabolic process (GO:0046459) | 4.89843628 |
| 44 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.87080964 |
| 45 | peptide hormone processing (GO:0016486) | 4.83969819 |
| 46 | glycoside metabolic process (GO:0016137) | 4.77745929 |
| 47 | metanephric nephron epithelium development (GO:0072243) | 4.74870876 |
| 48 | oligosaccharide catabolic process (GO:0009313) | 4.74154093 |
| 49 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.71836453 |
| 50 | virion attachment to host cell (GO:0019062) | 4.70585951 |
| 51 | adhesion of symbiont to host cell (GO:0044650) | 4.70585951 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.65703417 |
| 53 | peptide catabolic process (GO:0043171) | 4.62256194 |
| 54 | glutathione biosynthetic process (GO:0006750) | 4.61079047 |
| 55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.59960765 |
| 56 | digestion (GO:0007586) | 4.59040845 |
| 57 | diacylglycerol metabolic process (GO:0046339) | 4.49557333 |
| 58 | alkaloid metabolic process (GO:0009820) | 4.48859282 |
| 59 | renal system process involved in regulation of blood volume (GO:0001977) | 4.48818789 |
| 60 | proline metabolic process (GO:0006560) | 4.45959779 |
| 61 | branched-chain amino acid metabolic process (GO:0009081) | 4.42008787 |
| 62 | flavonoid metabolic process (GO:0009812) | 4.39907736 |
| 63 | vitamin transmembrane transport (GO:0035461) | 4.39526921 |
| 64 | regulation of cGMP metabolic process (GO:0030823) | 4.35819863 |
| 65 | metanephric epithelium development (GO:0072207) | 4.35213054 |
| 66 | vitamin A metabolic process (GO:0006776) | 4.33821179 |
| 67 | fat-soluble vitamin metabolic process (GO:0006775) | 4.31379530 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 4.28667863 |
| 69 | fructose metabolic process (GO:0006000) | 4.27049778 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 4.25793539 |
| 71 | tryptophan catabolic process (GO:0006569) | 4.25793539 |
| 72 | indole-containing compound catabolic process (GO:0042436) | 4.25793539 |
| 73 | urea cycle (GO:0000050) | 4.24146233 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 4.19992782 |
| 75 | nephron tubule development (GO:0072080) | 4.18041872 |
| 76 | aromatic amino acid family catabolic process (GO:0009074) | 4.18004591 |
| 77 | urea metabolic process (GO:0019627) | 4.14829311 |
| 78 | NADH metabolic process (GO:0006734) | 4.14776870 |
| 79 | cellular response to nitric oxide (GO:0071732) | 4.11230431 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 4.10728659 |
| 81 | regulation of cellular extravasation (GO:0002691) | 4.10302617 |
| 82 | sulfur compound transport (GO:0072348) | 4.09325524 |
| 83 | tryptophan metabolic process (GO:0006568) | 4.08566838 |
| 84 | angiotensin maturation (GO:0002003) | 4.07702025 |
| 85 | drinking behavior (GO:0042756) | 4.05520488 |
| 86 | polyol transport (GO:0015791) | 4.01471529 |
| 87 | L-phenylalanine catabolic process (GO:0006559) | 3.99922796 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.99922796 |
| 89 | vitamin biosynthetic process (GO:0009110) | 3.99607731 |
| 90 | L-phenylalanine metabolic process (GO:0006558) | 3.94510877 |
| 91 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.94510877 |
| 92 | valine metabolic process (GO:0006573) | 3.93655493 |
| 93 | serine family amino acid catabolic process (GO:0009071) | 3.90963189 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.89918950 |
| 95 | fatty acid beta-oxidation (GO:0006635) | 3.89476748 |
| 96 | peptide biosynthetic process (GO:0043043) | 3.88643246 |
| 97 | cGMP biosynthetic process (GO:0006182) | 3.88102081 |
| 98 | response to parathyroid hormone (GO:0071107) | 3.88003546 |
| 99 | adhesion of symbiont to host (GO:0044406) | 3.86750796 |
| 100 | carnitine metabolic process (GO:0009437) | 3.86157710 |
| 101 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.84749972 |
| 102 | serine family amino acid metabolic process (GO:0009069) | 3.77598735 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.77128733 |
| 104 | nitrogen cycle metabolic process (GO:0071941) | 3.75834841 |
| 105 | cellular response to vitamin D (GO:0071305) | 3.72593708 |
| 106 | vitamin transport (GO:0051180) | 3.72262546 |
| 107 | renal tubule development (GO:0061326) | 3.72214034 |
| 108 | bile acid metabolic process (GO:0008206) | 3.71359934 |
| 109 | protein-lipid complex assembly (GO:0065005) | 3.70109205 |
| 110 | response to phenylpropanoid (GO:0080184) | 3.69991375 |
| 111 | actin filament depolymerization (GO:0030042) | 3.69699744 |
| 112 | L-ascorbic acid metabolic process (GO:0019852) | 3.67247845 |
| 113 | glycolipid catabolic process (GO:0019377) | 3.66284961 |
| 114 | transepithelial transport (GO:0070633) | 3.64484951 |
| 115 | acetyl-CoA metabolic process (GO:0006084) | 3.64440692 |
| 116 | drug metabolic process (GO:0017144) | 3.60118123 |
| 117 | branched-chain amino acid catabolic process (GO:0009083) | 3.58445814 |
| 118 | glycosphingolipid catabolic process (GO:0046479) | 3.58030945 |
| 119 | glycerol metabolic process (GO:0006071) | 3.57965058 |
| 120 | phospholipid efflux (GO:0033700) | 3.57791390 |
| 121 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.57469611 |
| 122 | fatty acid oxidation (GO:0019395) | 3.56460826 |
| 123 | heme transport (GO:0015886) | 3.56332899 |
| 124 | omega-hydroxylase P450 pathway (GO:0097267) | 3.54878843 |
| 125 | cellular ketone body metabolic process (GO:0046950) | 3.52709349 |
| 126 | lipid oxidation (GO:0034440) | 3.49943787 |
| 127 | arginine metabolic process (GO:0006525) | 3.49868462 |
| 128 | cellular carbohydrate catabolic process (GO:0044275) | 3.48271500 |
| 129 | regulation of vitamin metabolic process (GO:0030656) | 3.47536415 |
| 130 | * sodium ion transport (GO:0006814) | 3.46349363 |
| 131 | sodium-independent organic anion transport (GO:0043252) | 3.45628484 |
| 132 | quinone biosynthetic process (GO:1901663) | 3.45116718 |
| 133 | glycosylceramide metabolic process (GO:0006677) | 3.44114351 |
| 134 | glutamate metabolic process (GO:0006536) | 3.43473108 |
| 135 | indole-containing compound metabolic process (GO:0042430) | 3.43434898 |
| 136 | positive regulation of cGMP metabolic process (GO:0030825) | 3.40945799 |
| 137 | response to growth hormone (GO:0060416) | 3.40858790 |
| 138 | nephron epithelium development (GO:0072009) | 3.39873297 |
| 139 | sulfate transmembrane transport (GO:1902358) | 3.39563485 |
| 140 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.36775178 |
| 141 | uronic acid metabolic process (GO:0006063) | 3.36682876 |
| 142 | glucuronate metabolic process (GO:0019585) | 3.36682876 |
| 143 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.33166002 |
| 144 | beta-amyloid metabolic process (GO:0050435) | 3.32489558 |
| 145 | regulation of cholesterol esterification (GO:0010872) | 3.31793021 |
| 146 | polyol catabolic process (GO:0046174) | 3.30729496 |
| 147 | cellular response to reactive nitrogen species (GO:1902170) | 3.30377927 |
| 148 | response to nitric oxide (GO:0071731) | 3.29971758 |
| 149 | glomerulus development (GO:0032835) | 3.29254810 |
| 150 | proline transport (GO:0015824) | 3.25229960 |
| 151 | fatty acid catabolic process (GO:0009062) | 3.24585021 |
| 152 | intestinal absorption (GO:0050892) | 3.24545097 |
| 153 | tricarboxylic acid cycle (GO:0006099) | 3.24499131 |
| 154 | mRNA modification (GO:0016556) | 3.24327119 |
| 155 | phenol-containing compound catabolic process (GO:0019336) | 3.24086874 |
| 156 | bicarbonate transport (GO:0015701) | 3.23461445 |
| 157 | midgut development (GO:0007494) | 3.23223558 |
| 158 | glutathione metabolic process (GO:0006749) | 3.23042643 |
| 159 | response to magnesium ion (GO:0032026) | 3.22672146 |
| 160 | regulation of protein glycosylation (GO:0060049) | 3.20984909 |
| 161 | cobalamin metabolic process (GO:0009235) | 3.20306354 |
| 162 | neurotransmitter biosynthetic process (GO:0042136) | 3.19944343 |
| 163 | cellular amino acid catabolic process (GO:0009063) | 3.19446752 |
| 164 | nephron epithelium morphogenesis (GO:0072088) | 3.19419136 |
| 165 | nephron tubule morphogenesis (GO:0072078) | 3.19419136 |
| 166 | alditol metabolic process (GO:0019400) | 3.18510567 |
| 167 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.18031484 |
| 168 | sphingomyelin metabolic process (GO:0006684) | 3.17907234 |
| 169 | auditory receptor cell differentiation (GO:0042491) | 3.16948296 |
| 170 | sodium ion homeostasis (GO:0055078) | 3.16633502 |
| 171 | cGMP-mediated signaling (GO:0019934) | 3.15870665 |
| 172 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.14949721 |
| 173 | leukotriene metabolic process (GO:0006691) | 3.14166687 |
| 174 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.7008847 |
| 175 | urate metabolic process (GO:0046415) | 10.1668308 |
| 176 | drug transmembrane transport (GO:0006855) | 10.0123181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.59214332 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.97763070 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.34264787 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17029076 |
| 5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.12971967 |
| 6 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.83462129 |
| 7 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.69614925 |
| 8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64826820 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.57897278 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.52638556 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.34941749 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.24658349 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19882028 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04044311 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82907022 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.82036899 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.81909760 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80177895 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76995946 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76793135 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.75467828 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74655378 |
| 23 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.73460479 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.70824800 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70571465 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.70339264 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64663410 |
| 28 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62650699 |
| 29 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62182026 |
| 30 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.59772091 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.57105728 |
| 32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.53529114 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50317155 |
| 34 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.49794033 |
| 35 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.48723216 |
| 36 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.48065412 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43184034 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.42998098 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.40329923 |
| 40 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.40316880 |
| 41 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.36232828 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.32339697 |
| 43 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.32152883 |
| 44 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.31974666 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31262078 |
| 46 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.30137242 |
| 47 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.27927903 |
| 48 | P300_19829295_ChIP-Seq_ESCs_Human | 1.27058746 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.26809278 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26678304 |
| 51 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23972881 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23020939 |
| 53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21282382 |
| 54 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20432465 |
| 55 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19992191 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19087541 |
| 57 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.18988398 |
| 58 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18656130 |
| 59 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.18578026 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.16698178 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15474833 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14908452 |
| 63 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13306283 |
| 64 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12365132 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11862822 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11756401 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.11637591 |
| 68 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.09648056 |
| 69 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09505478 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09496896 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08675495 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08139210 |
| 73 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07848802 |
| 74 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.07520114 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06966142 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04841468 |
| 77 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04840315 |
| 78 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04725578 |
| 79 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.03405578 |
| 80 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02898647 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02826954 |
| 82 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02397578 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00990323 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00842238 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.99967291 |
| 86 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99902986 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99278461 |
| 88 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98409907 |
| 89 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98409907 |
| 90 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.97768150 |
| 91 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.97694223 |
| 92 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97531511 |
| 93 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.97283301 |
| 94 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97215318 |
| 95 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97010281 |
| 96 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.96798184 |
| 97 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.96569218 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95406110 |
| 99 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.94455927 |
| 100 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94293316 |
| 101 | TBL1_22424771_ChIP-Seq_293T_Human | 0.94123675 |
| 102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93550764 |
| 103 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.93449549 |
| 104 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.93129975 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92610931 |
| 106 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.92406084 |
| 107 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.92275557 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92226943 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.91132410 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89878174 |
| 111 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89537454 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.88903373 |
| 113 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87585675 |
| 114 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.87526647 |
| 115 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87500177 |
| 116 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.87051853 |
| 117 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87008713 |
| 118 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86436811 |
| 119 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85444414 |
| 120 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85444414 |
| 121 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84840980 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.84390428 |
| 123 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.83615315 |
| 124 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.83538088 |
| 125 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.82116757 |
| 126 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.81785907 |
| 127 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.80452127 |
| 128 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.80450878 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79846393 |
| 130 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79846393 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79152533 |
| 132 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79012400 |
| 133 | KDM2B_26808549_Chip-Seq_REH_Human | 0.78942285 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.78888629 |
| 135 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.78646347 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.78611815 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78322425 |
| 138 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.77435783 |
| 139 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.77261355 |
| 140 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.76229873 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75581371 |
| 142 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75213175 |
| 143 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.74830845 |
| 144 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74671280 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74639711 |
| 146 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.74230087 |
| 147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74044223 |
| 148 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.73065720 |
| 149 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.73065720 |
| 150 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72697200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 9.04601596 |
| 2 | MP0004043_abnormal_pH_regulation | 6.70175104 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.16404840 |
| 4 | MP0005332_abnormal_amino_acid | 4.55124891 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.20824904 |
| 6 | MP0003195_calcinosis | 4.09855503 |
| 7 | MP0001765_abnormal_ion_homeostasis | 3.73166368 |
| 8 | MP0009643_abnormal_urine_homeostasis | 3.69422182 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.39942322 |
| 10 | MP0003878_abnormal_ear_physiology | 3.26228682 |
| 11 | MP0005377_hearing/vestibular/ear_phenot | 3.26228682 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 3.00015949 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.98941478 |
| 14 | MP0009379_abnormal_foot_pigmentation | 2.92070167 |
| 15 | MP0003252_abnormal_bile_duct | 2.90692659 |
| 16 | MP0002136_abnormal_kidney_physiology | 2.81371218 |
| 17 | MP0001756_abnormal_urination | 2.77697334 |
| 18 | MP0001958_emphysema | 2.47727244 |
| 19 | MP0005365_abnormal_bile_salt | 2.05754174 |
| 20 | MP0005085_abnormal_gallbladder_physiolo | 2.04461329 |
| 21 | MP0000538_abnormal_urinary_bladder | 1.98636335 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.96573811 |
| 23 | MP0003868_abnormal_feces_composition | 1.89188557 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.88766109 |
| 25 | MP0005409_darkened_coat_color | 1.79352691 |
| 26 | MP0003718_maternal_effect | 1.77782861 |
| 27 | MP0005084_abnormal_gallbladder_morpholo | 1.76139281 |
| 28 | MP0008961_abnormal_basal_metabolism | 1.71099131 |
| 29 | MP0005451_abnormal_body_composition | 1.65852010 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.54663514 |
| 31 | MP0001188_hyperpigmentation | 1.52451343 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.46205101 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42972619 |
| 34 | MP0004147_increased_porphyrin_level | 1.42146974 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.39430544 |
| 36 | MP0003283_abnormal_digestive_organ | 1.39229712 |
| 37 | MP0002822_catalepsy | 1.38437623 |
| 38 | MP0004885_abnormal_endolymph | 1.34734869 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.34593102 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.33866931 |
| 41 | MP0003186_abnormal_redox_activity | 1.28833396 |
| 42 | MP0004270_analgesia | 1.28169880 |
| 43 | MP0000490_abnormal_crypts_of | 1.23083275 |
| 44 | MP0000230_abnormal_systemic_arterial | 1.20813160 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.15112436 |
| 46 | MP0002168_other_aberrant_phenotype | 1.11507351 |
| 47 | MP0002928_abnormal_bile_duct | 1.10772800 |
| 48 | MP0000477_abnormal_intestine_morphology | 1.06612481 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.02955911 |
| 50 | MP0001764_abnormal_homeostasis | 1.02176732 |
| 51 | MP0005448_abnormal_energy_balance | 1.01150463 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.00296919 |
| 53 | MP0002135_abnormal_kidney_morphology | 1.00245799 |
| 54 | MP0010329_abnormal_lipoprotein_level | 0.96556379 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 0.95073433 |
| 56 | MP0005535_abnormal_body_temperature | 0.91878241 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.91129842 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.90641381 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 0.89970218 |
| 60 | MP0002971_abnormal_brown_adipose | 0.88919294 |
| 61 | MP0002896_abnormal_bone_mineralization | 0.84008924 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 0.83035079 |
| 63 | MP0005174_abnormal_tail_pigmentation | 0.80425608 |
| 64 | MP0003638_abnormal_response/metabolism_ | 0.79970828 |
| 65 | MP0009764_decreased_sensitivity_to | 0.79634962 |
| 66 | MP0003646_muscle_fatigue | 0.78240604 |
| 67 | MP0005670_abnormal_white_adipose | 0.77378606 |
| 68 | MP0009642_abnormal_blood_homeostasis | 0.73598700 |
| 69 | MP0005395_other_phenotype | 0.72141571 |
| 70 | MP0009115_abnormal_fat_cell | 0.71046697 |
| 71 | MP0001664_abnormal_digestion | 0.70785255 |
| 72 | MP0005666_abnormal_adipose_tissue | 0.69969522 |
| 73 | MP0010386_abnormal_urinary_bladder | 0.69649448 |
| 74 | MP0001873_stomach_inflammation | 0.68738689 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.67010135 |
| 76 | MP0003806_abnormal_nucleotide_metabolis | 0.65811363 |
| 77 | MP0001663_abnormal_digestive_system | 0.65423667 |
| 78 | MP0003879_abnormal_hair_cell | 0.64291583 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.63310316 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.63087804 |
| 81 | MP0005367_renal/urinary_system_phenotyp | 0.63001258 |
| 82 | MP0000516_abnormal_urinary_system | 0.63001258 |
| 83 | MP0000427_abnormal_hair_cycle | 0.61550605 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.57677524 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.56042956 |
| 86 | MP0005381_digestive/alimentary_phenotyp | 0.55695247 |
| 87 | MP0000537_abnormal_urethra_morphology | 0.54673774 |
| 88 | MP0003866_abnormal_defecation | 0.53053656 |
| 89 | MP0000609_abnormal_liver_physiology | 0.51986951 |
| 90 | MP0004742_abnormal_vestibular_system | 0.49697771 |
| 91 | MP0002098_abnormal_vibrissa_morphology | 0.49549361 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.49257854 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.49215661 |
| 94 | MP0002796_impaired_skin_barrier | 0.49102266 |
| 95 | MP0009697_abnormal_copulation | 0.48590745 |
| 96 | MP0003953_abnormal_hormone_level | 0.48328475 |
| 97 | MP0000371_diluted_coat_color | 0.48025264 |
| 98 | MP0002069_abnormal_eating/drinking_beha | 0.47828264 |
| 99 | MP0005334_abnormal_fat_pad | 0.47690426 |
| 100 | MP0008469_abnormal_protein_level | 0.46425771 |
| 101 | MP0002078_abnormal_glucose_homeostasis | 0.46235728 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.45797710 |
| 103 | MP0001485_abnormal_pinna_reflex | 0.44934230 |
| 104 | MP0004484_altered_response_of | 0.44446275 |
| 105 | MP0002115_abnormal_skeleton_extremities | 0.44405135 |
| 106 | MP0002998_abnormal_bone_remodeling | 0.41712444 |
| 107 | MP0006138_congestive_heart_failure | 0.41696693 |
| 108 | MP0005376_homeostasis/metabolism_phenot | 0.40976118 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.40873364 |
| 110 | MP0003959_abnormal_lean_body | 0.40867534 |
| 111 | MP0005501_abnormal_skin_physiology | 0.40698690 |
| 112 | MP0008775_abnormal_heart_ventricle | 0.39912006 |
| 113 | MP0005165_increased_susceptibility_to | 0.39719222 |
| 114 | MP0001963_abnormal_hearing_physiology | 0.39534885 |
| 115 | MP0001177_atelectasis | 0.38710200 |
| 116 | MP0000534_abnormal_ureter_morphology | 0.38515019 |
| 117 | MP0003795_abnormal_bone_structure | 0.38389150 |
| 118 | MP0005551_abnormal_eye_electrophysiolog | 0.37494785 |
| 119 | MP0000249_abnormal_blood_vessel | 0.37417805 |
| 120 | MP0000163_abnormal_cartilage_morphology | 0.35178550 |
| 121 | MP0000598_abnormal_liver_morphology | 0.34901323 |
| 122 | MP0005408_hypopigmentation | 0.34813705 |
| 123 | MP0009840_abnormal_foam_cell | 0.34614535 |
| 124 | MP0004085_abnormal_heartbeat | 0.34406577 |
| 125 | MP0005167_abnormal_blood-brain_barrier | 0.34021949 |
| 126 | MP0002638_abnormal_pupillary_reflex | 0.33686393 |
| 127 | MP0004858_abnormal_nervous_system | 0.32938552 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.31999459 |
| 129 | MP0008872_abnormal_physiological_respon | 0.30690588 |
| 130 | MP0000462_abnormal_digestive_system | 0.30475919 |
| 131 | MP0000747_muscle_weakness | 0.29563301 |
| 132 | MP0005166_decreased_susceptibility_to | 0.29004934 |
| 133 | MP0002909_abnormal_adrenal_gland | 0.27820901 |
| 134 | MP0000566_synostosis | 0.27423061 |
| 135 | MP0005410_abnormal_fertilization | 0.26574343 |
| 136 | MP0001661_extended_life_span | 0.25979724 |
| 137 | MP0005310_abnormal_salivary_gland | 0.25881765 |
| 138 | MP0001731_abnormal_postnatal_growth | 0.25678988 |
| 139 | MP0000026_abnormal_inner_ear | 0.25537199 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 8.25305664 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.26678446 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.25427279 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.12259695 |
| 5 | Hypomagnesemia (HP:0002917) | 6.93672595 |
| 6 | Polyuria (HP:0000103) | 6.67426569 |
| 7 | Gout (HP:0001997) | 6.55378125 |
| 8 | Abnormal urine output (HP:0012590) | 6.44683550 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 6.33009673 |
| 10 | Abnormality of renal excretion (HP:0011036) | 6.13166586 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.93197610 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 5.72266364 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.55595951 |
| 14 | Proximal tubulopathy (HP:0000114) | 5.53700035 |
| 15 | Abnormal drinking behavior (HP:0030082) | 5.34267219 |
| 16 | Polydipsia (HP:0001959) | 5.34267219 |
| 17 | Tetany (HP:0001281) | 4.99728872 |
| 18 | Abnormality of renin-angiotensin system (HP:0000847) | 4.93947988 |
| 19 | Chronic diarrhea (HP:0002028) | 4.91742857 |
| 20 | Hyperglycinuria (HP:0003108) | 4.91295278 |
| 21 | Hyperaldosteronism (HP:0000859) | 4.75656739 |
| 22 | Alkalosis (HP:0001948) | 4.75585072 |
| 23 | Increased purine levels (HP:0004368) | 4.65594931 |
| 24 | Hyperuricemia (HP:0002149) | 4.65594931 |
| 25 | Renal salt wasting (HP:0000127) | 4.56848762 |
| 26 | Acanthocytosis (HP:0001927) | 4.56415134 |
| 27 | Ileus (HP:0002595) | 4.40692119 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 4.35036428 |
| 29 | Fat malabsorption (HP:0002630) | 4.28768789 |
| 30 | Hypercalciuria (HP:0002150) | 4.17983996 |
| 31 | Abnormality of vitamin metabolism (HP:0100508) | 4.12889593 |
| 32 | Generalized aminoaciduria (HP:0002909) | 4.06987981 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 4.05917961 |
| 34 | Glycosuria (HP:0003076) | 3.98020414 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 3.98020414 |
| 36 | Hydroxyprolinuria (HP:0003080) | 3.97770560 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 3.97770560 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.87215353 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87215353 |
| 40 | Hypokalemia (HP:0002900) | 3.78911101 |
| 41 | Renal tubular acidosis (HP:0001947) | 3.59752809 |
| 42 | Widely patent fontanelles and sutures (HP:0004492) | 3.37170036 |
| 43 | Ketoacidosis (HP:0001993) | 3.37069845 |
| 44 | Megaloblastic anemia (HP:0001889) | 3.34509158 |
| 45 | Hyperphosphaturia (HP:0003109) | 3.33600738 |
| 46 | Abnormality of nucleobase metabolism (HP:0010932) | 3.30964700 |
| 47 | Abnormal urine phosphate concentration (HP:0012599) | 3.25285098 |
| 48 | Congenital sensorineural hearing impairment (HP:0008527) | 3.24043452 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 3.22696333 |
| 50 | Abnormality of potassium homeostasis (HP:0011042) | 3.19532667 |
| 51 | Nephrolithiasis (HP:0000787) | 3.01761448 |
| 52 | Nephrocalcinosis (HP:0000121) | 2.97124372 |
| 53 | Posterior subcapsular cataract (HP:0007787) | 2.85354440 |
| 54 | Hypophosphatemia (HP:0002148) | 2.85283770 |
| 55 | Ketosis (HP:0001946) | 2.84985527 |
| 56 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.81817811 |
| 57 | Dehydration (HP:0001944) | 2.81261222 |
| 58 | Xanthomatosis (HP:0000991) | 2.79516815 |
| 59 | Steatorrhea (HP:0002570) | 2.78310183 |
| 60 | Hypolipoproteinemia (HP:0010981) | 2.70702550 |
| 61 | Malnutrition (HP:0004395) | 2.66660275 |
| 62 | Facial shape deformation (HP:0011334) | 2.61378209 |
| 63 | Potter facies (HP:0002009) | 2.61378209 |
| 64 | Abdominal distention (HP:0003270) | 2.57923658 |
| 65 | Rickets (HP:0002748) | 2.57605698 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.56557696 |
| 67 | Chorioretinal atrophy (HP:0000533) | 2.50716633 |
| 68 | Vascular calcification (HP:0004934) | 2.48239697 |
| 69 | Epidermoid cyst (HP:0200040) | 2.45036852 |
| 70 | Focal segmental glomerulosclerosis (HP:0000097) | 2.39090982 |
| 71 | Confusion (HP:0001289) | 2.36743775 |
| 72 | Renal tubular dysfunction (HP:0000124) | 2.35305007 |
| 73 | Thin bony cortex (HP:0002753) | 2.31917278 |
| 74 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.30315871 |
| 75 | Metaphyseal cupping (HP:0003021) | 2.29739244 |
| 76 | Abnormality of sodium homeostasis (HP:0010931) | 2.29429312 |
| 77 | Abnormality of renal resorption (HP:0011038) | 2.28778359 |
| 78 | Hyponatremia (HP:0002902) | 2.27705583 |
| 79 | Enlarged kidneys (HP:0000105) | 2.26811972 |
| 80 | Hyperglycinemia (HP:0002154) | 2.24735126 |
| 81 | Metabolic acidosis (HP:0001942) | 2.23718890 |
| 82 | Abnormality of the costochondral junction (HP:0000919) | 2.23243011 |
| 83 | Hyperammonemia (HP:0001987) | 2.20676118 |
| 84 | Delayed CNS myelination (HP:0002188) | 2.20178432 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 2.19850253 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.18352749 |
| 87 | Vomiting (HP:0002013) | 2.11857783 |
| 88 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.11753742 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 2.11457917 |
| 90 | Adrenal overactivity (HP:0002717) | 2.10534860 |
| 91 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10491355 |
| 92 | Poikilocytosis (HP:0004447) | 2.10031300 |
| 93 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.07327746 |
| 94 | Abnormal glucose tolerance (HP:0001952) | 2.06376577 |
| 95 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.06348134 |
| 96 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.01944168 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01101809 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 2.01101809 |
| 99 | Metaphyseal irregularity (HP:0003025) | 1.96078334 |
| 100 | Tubular atrophy (HP:0000092) | 1.95058864 |
| 101 | Chondrocalcinosis (HP:0000934) | 1.94967897 |
| 102 | Hypoalbuminemia (HP:0003073) | 1.93519029 |
| 103 | Abnormal albumin level (HP:0012116) | 1.93519029 |
| 104 | Hyperventilation (HP:0002883) | 1.91738803 |
| 105 | Tubulointerstitial fibrosis (HP:0005576) | 1.91338253 |
| 106 | Subcapsular cataract (HP:0000523) | 1.91029007 |
| 107 | Wide cranial sutures (HP:0010537) | 1.89821320 |
| 108 | Protuberant abdomen (HP:0001538) | 1.88389975 |
| 109 | Abnormality of Sharpey fibers (HP:0100685) | 1.86702207 |
| 110 | Hypotension (HP:0002615) | 1.85014003 |
| 111 | Polyphagia (HP:0002591) | 1.82923115 |
| 112 | Bicornuate uterus (HP:0000813) | 1.81673850 |
| 113 | Methylmalonic aciduria (HP:0012120) | 1.81528981 |
| 114 | Nausea (HP:0002018) | 1.81385102 |
| 115 | Lethargy (HP:0001254) | 1.80896732 |
| 116 | Villous atrophy (HP:0011473) | 1.80479076 |
| 117 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80479076 |
| 118 | Cerebral palsy (HP:0100021) | 1.79058806 |
| 119 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.78905750 |
| 120 | Enlarged epiphyses (HP:0010580) | 1.78322666 |
| 121 | Abnormal eating behavior (HP:0100738) | 1.77585270 |
| 122 | Abnormal tarsal ossification (HP:0008369) | 1.76644021 |
| 123 | Hyperparathyroidism (HP:0000843) | 1.75925363 |
| 124 | Glomerulosclerosis (HP:0000096) | 1.75372209 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.67330747 |
| 126 | Abnormality of vitamin B metabolism (HP:0004340) | 1.65778073 |
| 127 | Elevated alkaline phosphatase (HP:0003155) | 1.64529596 |
| 128 | Irritability (HP:0000737) | 1.63501583 |
| 129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.60847878 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.58897260 |
| 131 | Generalized muscle weakness (HP:0003324) | 1.57897336 |
| 132 | Sensorimotor neuropathy (HP:0007141) | 1.56044923 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 9.10138662 |
| 2 | SRC | 9.07726060 |
| 3 | WNK4 | 8.76026211 |
| 4 | WNK3 | 8.63639170 |
| 5 | OXSR1 | 7.89541739 |
| 6 | STK39 | 4.32233322 |
| 7 | STK38L | 2.44162015 |
| 8 | TNIK | 2.16225181 |
| 9 | BCKDK | 2.06216452 |
| 10 | SGK223 | 1.88900506 |
| 11 | SGK494 | 1.88900506 |
| 12 | MST4 | 1.88313753 |
| 13 | WNK1 | 1.70889807 |
| 14 | EPHA2 | 1.65388977 |
| 15 | PDK3 | 1.62986468 |
| 16 | PDK4 | 1.62986468 |
| 17 | MST1R | 1.60830213 |
| 18 | MAP3K12 | 1.44363812 |
| 19 | NEK1 | 1.31987632 |
| 20 | ADRBK2 | 1.22623328 |
| 21 | SGK2 | 1.22415847 |
| 22 | PDK2 | 1.18589208 |
| 23 | STK38 | 1.15754362 |
| 24 | SGK3 | 1.07701989 |
| 25 | GRK6 | 1.05518606 |
| 26 | FRK | 1.05362762 |
| 27 | DDR2 | 1.00297518 |
| 28 | ERBB2 | 0.98140685 |
| 29 | EPHA3 | 0.92111378 |
| 30 | NLK | 0.90573057 |
| 31 | INSRR | 0.87272010 |
| 32 | MATK | 0.84670903 |
| 33 | BRSK2 | 0.84488231 |
| 34 | PIK3CA | 0.83823323 |
| 35 | STK24 | 0.71780407 |
| 36 | TESK2 | 0.71347799 |
| 37 | FGFR4 | 0.71136687 |
| 38 | MAP3K7 | 0.70961952 |
| 39 | MAP2K2 | 0.70381740 |
| 40 | BMPR1B | 0.62840612 |
| 41 | MAP4K2 | 0.62132920 |
| 42 | SGK1 | 0.61397144 |
| 43 | GSK3A | 0.60439677 |
| 44 | STK3 | 0.60303548 |
| 45 | PINK1 | 0.58385984 |
| 46 | AKT3 | 0.57636645 |
| 47 | PRKAA1 | 0.57151199 |
| 48 | EPHB1 | 0.54173584 |
| 49 | DAPK2 | 0.53044707 |
| 50 | PRKAA2 | 0.52680392 |
| 51 | LRRK2 | 0.51730001 |
| 52 | TEC | 0.51601649 |
| 53 | LATS1 | 0.51297409 |
| 54 | TYK2 | 0.50914368 |
| 55 | MAP3K2 | 0.50107192 |
| 56 | ERBB4 | 0.49788158 |
| 57 | PTK2 | 0.48907040 |
| 58 | MAP3K14 | 0.46777177 |
| 59 | PRKCI | 0.44839393 |
| 60 | MAP2K6 | 0.43611889 |
| 61 | NME1 | 0.43530293 |
| 62 | NEK2 | 0.43417276 |
| 63 | MAPK11 | 0.43299879 |
| 64 | CAMK2D | 0.42408125 |
| 65 | MAP3K3 | 0.42141094 |
| 66 | CDK19 | 0.41621001 |
| 67 | PLK4 | 0.41593024 |
| 68 | PTK6 | 0.40891668 |
| 69 | PDPK1 | 0.40091597 |
| 70 | BCR | 0.39938926 |
| 71 | TIE1 | 0.38953637 |
| 72 | DYRK1B | 0.38289748 |
| 73 | NEK6 | 0.36533904 |
| 74 | CAMK2A | 0.34696758 |
| 75 | STK10 | 0.33662082 |
| 76 | MET | 0.32898687 |
| 77 | IRAK3 | 0.32783791 |
| 78 | PRKD2 | 0.31504619 |
| 79 | CASK | 0.31270627 |
| 80 | BMPR2 | 0.30867750 |
| 81 | ERN1 | 0.30221199 |
| 82 | FER | 0.29444684 |
| 83 | PRKCZ | 0.29333665 |
| 84 | PAK4 | 0.28629902 |
| 85 | ERBB3 | 0.27696485 |
| 86 | PAK3 | 0.26999734 |
| 87 | PRKG2 | 0.26081346 |
| 88 | MAP4K1 | 0.25640442 |
| 89 | MAP3K1 | 0.25510181 |
| 90 | LMTK2 | 0.25067347 |
| 91 | PDK1 | 0.25054418 |
| 92 | PRKCB | 0.24346682 |
| 93 | PRKG1 | 0.23753014 |
| 94 | YES1 | 0.22683383 |
| 95 | ABL2 | 0.22619595 |
| 96 | MYLK | 0.21215925 |
| 97 | PRKCD | 0.20903431 |
| 98 | CAMK2B | 0.20703935 |
| 99 | STK11 | 0.20651417 |
| 100 | MUSK | 0.20288434 |
| 101 | MAP3K6 | 0.20159898 |
| 102 | MAPK15 | 0.18902797 |
| 103 | PRKACG | 0.18627982 |
| 104 | NTRK3 | 0.18203494 |
| 105 | AKT2 | 0.17998743 |
| 106 | TTK | 0.17623514 |
| 107 | RIPK1 | 0.16933146 |
| 108 | PRKCA | 0.16679471 |
| 109 | BMX | 0.15147512 |
| 110 | PRKACA | 0.14247969 |
| 111 | EPHA4 | 0.12716067 |
| 112 | PRKCH | 0.11326914 |
| 113 | MAP2K4 | 0.09861197 |
| 114 | TGFBR2 | 0.09527458 |
| 115 | SIK3 | 0.09490215 |
| 116 | EPHB2 | 0.08800518 |
| 117 | PTK2B | 0.07573044 |
| 118 | PIM1 | 0.07067860 |
| 119 | PRKCE | 0.06801154 |
| 120 | ROCK1 | 0.06672644 |
| 121 | NUAK1 | 0.06015566 |
| 122 | GRK1 | 0.05266977 |
| 123 | MAP3K13 | 0.05098167 |
| 124 | MELK | 0.05051054 |
| 125 | FGFR3 | 0.02932289 |
| 126 | INSR | 0.02900645 |
| 127 | PIK3CG | 0.02755138 |
| 128 | NTRK1 | 0.02625846 |
| 129 | CSNK1A1 | 0.02475584 |
| 130 | ITK | 0.02120496 |
| 131 | PRKCQ | 0.02013083 |
| 132 | PRKCG | 0.01562913 |
| 133 | MAP3K10 | 0.01461201 |
| 134 | IGF1R | 0.00914816 |
| 135 | IRAK1 | 0.00865143 |
| 136 | MAP3K9 | 0.00753108 |
| 137 | JAK2 | 0.00715144 |
| 138 | CSK | 0.00223328 |
| 139 | ADRBK1 | 0.00050895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.66454360 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44771170 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.38475404 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.34400860 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.06599584 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.95216511 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.91392388 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.84813990 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.76358872 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72368841 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47935066 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47071828 |
| 13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.41393530 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.26716085 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.21794637 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.21587000 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.20260752 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15566412 |
| 19 | Mineral absorption_Homo sapiens_hsa04978 | 2.10988450 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.97151978 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.88975408 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86276346 |
| 23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.82660530 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.78813326 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.74331131 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67083003 |
| 27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61459898 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.60851977 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52613226 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51524368 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49348994 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.45952717 |
| 33 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.45672228 |
| 34 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.36257646 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.35387453 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.28726387 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.28015638 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.25322036 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.19620865 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.18697404 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18223648 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14691470 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13304586 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.13296549 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11058397 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07097604 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06725666 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.05844033 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.99928591 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99901341 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.99509318 |
| 52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90849206 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.87807456 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80391772 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78803562 |
| 56 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77567111 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.65648770 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63168642 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62670836 |
| 60 | Asthma_Homo sapiens_hsa05310 | 0.61518959 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.60504242 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60364061 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58004207 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57287505 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55097780 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54406098 |
| 67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53229572 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 0.52021159 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.51738676 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51629956 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51621802 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.50553442 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47983847 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47900052 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45782399 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.45624628 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43411878 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.40067770 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38400519 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36745072 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36370887 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.36264487 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36100198 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34838405 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33681746 |
| 86 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33227905 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32057457 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29351928 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29016579 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.27266415 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.27247573 |
| 92 | Allograft rejection_Homo sapiens_hsa05330 | 0.26497245 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26368433 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.25105619 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24575409 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23466796 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23229612 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22911634 |
| 99 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.21775024 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.19290290 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.15936715 |
| 102 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15589149 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.13745542 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.10864501 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.10251873 |
| 106 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.09771319 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.06029443 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.05923189 |
| 109 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.04284960 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.03922369 |
| 111 | Insulin resistance_Homo sapiens_hsa04931 | 0.03167858 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.02893494 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.02320664 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.01896425 |
| 115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.01290768 |
| 116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0911654 |
| 117 | Phagosome_Homo sapiens_hsa04145 | -0.0796911 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0674862 |
| 119 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0672392 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0668222 |
| 121 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0645546 |
| 122 | Dopaminergic synapse_Homo sapiens_hsa04728 | -0.0459775 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | -0.0390580 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0381232 |
| 125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | -0.0080855 |

